aTyr Pharma Announces Partner Kyorin Pharmaceutical, Co., Ltd. Proceeds to Phase 1 Trial of ATYR1923 in Japan
Go back to aTyr Pharma Announces Partner Kyorin Pharmaceutical, Co., Ltd. Proceeds to Phase 1 Trial of ATYR1923 in Japan| Life Technologies Corporation (NASDAQ: LIFE) | Delayed: 42.27 +2.42 (6.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $39.85 | 52 Week High | $10.93 | |||
| Open | $39.76 | 52 Week Low | $2.48 | |||
| Day High | $42.50 | P/E | 15.60 | |||
| Day Low | $39.67 | EPS | $2.71 | |||
| Volume | 719,654 | |||||
